Clinical Trials Directory

Trials / Completed

CompletedNCT02701582

Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
66 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, randomized controlled trial to determine if using FloTrac/EV1000 system in neurosurgical patients undergoing craniotomies for aneurysm repair or tumor resection complicated by cerebral edema, or complex spinal surgery including multi-level scoliosis correction, is a more effective way of monitoring fluid.

Detailed description

We hypothesize that the ability to assess volume status and fluid responsiveness with information gained from Edwards FloTrac/EV1000 system coupled with a goal-directed therapy fluid management algorithm can make a difference in patient outcomes. Our specific aims are: * Demonstrate goal-directed therapy (GDT) in fluid management improves peri-operative fluid balance * Demonstrate GDT improves pulmonary function and organ oxygenation * Demonstrate GDT reduces necessary therapeutic interventions in the peri- operative period * Demonstrate GDT reduces hypotensive episodes in the peri-operative period Outcomes We will study the consequences of goal-directed fluid therapy that employs use of dynamic indicators seen on FloTrac/EV1000 system by measuring the following: * Pulmonary status * Time to extubation * Alveolar-arterial (A-a) gradient of oxygen * Requirements for supplemental oxygen * Organ oxygenation * Serum lactate * Arterial blood gas values (pH, HCO3, CO2, O2) * Length of stay (LOS) * In hospital, defined as time from operation start to eligibility for discharge from hospital according to surgeon in accordance with pre-define criteria * In ICU/PACU, defined as time from operation end to eligibility for discharge from intensive care according to attending intensivist in accordance with pre- define criteria * Fluid Balance * Inputs and outputs (I/Os) of all measurable fluids (i.e. blood, crystalloid, colloid) in peri-operative period, through and including duration of intensive care or the next 24-48 hours after completion of surgery * Drugs administered for fluid management (i.e. mannitol, vasopressors) * Pre-operative and post-operative body weights and twice-daily weights via bed weights * Hypotension * Number, duration and severity (i.e. minimum blood pressure) of hypotensive episode, defined as MAP \<65

Conditions

Interventions

TypeNameDescription
DRUGPhenylephrineif Mean arterial pressure (MAP) is \< = 65, Stroke volume variation (SVV) \< 13 and Cardiac Index is \>=2.2 Phenylephrine is administered
DRUGEpinephrineif Mean arterial pressure (MAP) is \< = 65, Stroke volume variation (SVV) \< 13 and Cardiac Index is \< 2.2 Epinephrine is administered
OTHERAlbuminif Mean arterial pressure (MAP) is \< = 65, Stroke volume variation (SVV) \> = 13, fluids are administered --OR-- if Mean arterial pressure (MAP) is \> 65, Stroke volume variation (SVV) \> = 13 and Cardiac Index is \<2.2 fluids are administered.
OTHERVoluvenif Mean arterial pressure (MAP) is \< = 65, Stroke volume variation (SVV) \> = 13, fluids are administered --OR-- if Mean arterial pressure (MAP) is \> 65, Stroke volume variation (SVV) \> = 13 and Cardiac Index is \<2.2 fluids are administered.
OTHERNormal Salineif Mean arterial pressure (MAP) is \< = 65, Stroke volume variation (SVV) \> = 13, fluids are administered --OR-- if Mean arterial pressure (MAP) is \> 65, Stroke volume variation (SVV) \> = 13 and Cardiac Index is \<2.2 fluids are administered.
OTHERPacked Red Blood Cellsif Mean arterial pressure (MAP) is \< = 65, Stroke volume variation (SVV) \> = 13, fluids are administered --OR-- if Mean arterial pressure (MAP) is \> 65, Stroke volume variation (SVV) \> = 13 and Cardiac Index is \<2.2 fluids are administered.
DEVICEFloTrac MonitorFloTrac monitor is connected for all patients, but only visible to the anesthesiologist for half. Based on a decision tree and the data from monitor, choices of interventions are used.

Timeline

Start date
2014-03-01
Primary completion
2016-01-01
Completion
2016-09-01
First posted
2016-03-08
Last updated
2019-08-28
Results posted
2019-08-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02701582. Inclusion in this directory is not an endorsement.